Gold 2025 Copd Gold. Why is postbronchodilator spirometry no longer recommended in the global initiative for chronic obstructive lung disease (gold) 2025 report as the first step in. The 2025 gold report on chronic obstructive pulmonary disease (copd) management has been updated with several notable changes, lourdes cross, pharmd,.
Han, a member of the gold scientific committee tasked with the recent update, then discussed the rationale for inclusion of the 2 new medications, emphasizing how the additions reflect a focus on disease. The 2025 gold recommendations include the addition of dupilumab as the first biologic treatment to reduce the frequency of copd exacerbations in stable copd.